With vaccines widely available in the US, and as restrictions are eased or eliminated, individual PCR testing of infected individuals alone is no longer practical for long-term monitoring and prevention of COVID-19 outbreaks. However, there is still risk of future outbreaks from viral variants.

Wastewater testing is a rapid, passive, and non-intrusive approach to assessing the infection burden in a community and overcomes the bias of access to medical care. This data can enable quicker and more targeted responses, including further individual testing, implementation of non-therapeutic public health action and rapid development and deployment of targeted treatments.

In partnership with Stanford University and the University of Michigan, Verily has developed a novel, sensitive and scalable method to measure levels of SARS-CoV-2 in wastewater.

Levels of N/PMMoV shown over 6 months in Northern California show the presence of COVID-19 in wastewater by month.

Our new whitepaper outlines our approach to regular, prospective monitoring of COVID-19 incidence rates. You will learn about:

  • How Verily’s platform was designed to take advantage of coronaviruses’ natural affinity for wastewater solids

  • Analysis methods that result in several orders of magnitude higher quantification than other approaches

  • The platform’s scalability across variations in wastewater and processing, exemplified by a case study of daily sampling at Northern California plants

Download the whitepaper to learn more.